How Much Calcium Is in Your Drinking Water? A Survey of Calcium Concentrations in Bottled and Tap Water and Their Significance for Medical Treatment and Drug Administration

IntroductionDifferent forms of water vary in calcium content. High divalent ion (i.e., Ca2+, Mg2+, etc.) concentration is deleterious to the absorption and efficacy of the bisphosphonate group of drugs in osteoporosis treatment. Water with high calcium concentration may also present an alternate pathway of calcium administration. In either case, knowing the actual concentration is critical.HypothesisThe current paper is a surveillance study. We hypothesize that there is considerable variation in the calcium concentrations in the various water sources: tap water from US and Canadian cities of different regions and purified, spring, and mineral bottled waters. In addition, we hypothesize that the water filter removes a significant amount of minerals including calcium from the water.MethodologyCalcium concentrations in various city tap waters, as well as an assorted number of bottled waters, were determined through the direct inspection of scientific data. The effect of filtering was also determined by mineral analysis of mineral water directly before and after filtration.ResultThe calcium concentration of water varies from 1 to 135 mg/L across the USA and Canada. Most spring waters were found to have a relatively low calcium concentration, with an average of 21.8 mg/L. Purified waters contain a negligible calcium concentration. Mineral waters, on the other hand, were generally found to contain higher calcium concentrations, an average of 208 mg/L of calcium. Filtration was found to remove a considerable amount of calcium from the water, removing 89% on average.ConclusionCalcium concentration in water varied substantially from different sources in the USA and Canada. Bottled waters presented with concentrations of calcium covering a very large range. Certain tap and bottled waters present with concentrations of calcium sufficient to exhibit a deleterious effect on bisphosphonate treatment. Alternatively, certain waters may be used as a source of calcium that may provide over 40% of the recommended daily intake for calcium.

[1]  I. Reid,et al.  Effect of calcium supplementation on bone loss in postmenopausal women. , 1993, The New England journal of medicine.

[2]  K. Resch,et al.  Calcium Supplementation with Calcium-Rich Mineral Waters: A Systematic Review and Meta-analysis of its Bioavailability , 2000, Osteoporosis International.

[3]  L. Pylkkänen,et al.  Timing of food intake has a marked effect on the bioavailability of clodronate. , 2000, Bone.

[4]  J. Lin,et al.  Bisphosphonates: a review of their pharmacokinetic properties. , 1996, Bone.

[5]  R. Recker,et al.  Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis , 1996 .

[6]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[7]  H. Fleisch,et al.  Sodium EDTA enhances intestinal absorption of two bisphosphonates , 1991, Calcified Tissue International.

[8]  R. Heaney,et al.  Absorption of Calcium as the Carbonate and Citrate Salts, with Some Observations on Method , 1999, Osteoporosis International.

[9]  G. Rennert,et al.  Calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche. , 2003, The American journal of clinical nutrition.

[10]  K. Goa,et al.  Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease. , 2001, Drugs.

[11]  G. Rodan,et al.  Preclinical pharmacology of alendronate , 2005, Osteoporosis International.

[12]  P. Geusens,et al.  Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. , 1996, Bone.

[13]  G. Guyatt,et al.  Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. , 2002, Endocrine reviews.

[14]  L. Davis Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. , 1998, Journal of nurse-midwifery.

[15]  Jacques P. Brown,et al.  Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .

[16]  D. Burr,et al.  Regional patterns of bone loss and altered bone remodeling in response to calcium deprivation in laboratory rabbits , 1990, Calcified Tissue International.

[17]  J Dequeker,et al.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.

[18]  M. Espallargues,et al.  Identifying Bone-Mass-Related Risk Factors for Fracture to Guide Bone Densitometry Measurements: A Systematic Review of the Literature , 2001, Osteoporosis International.

[19]  B. Gertz,et al.  Pharmacokinetics of Alendronate , 1999, Clinical pharmacokinetics.

[20]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[21]  B. Dawson-Hughes Vitamin D and Calcium: Recommended Intake for Bone Health , 1998, Osteoporosis International.

[22]  L. Schiller,et al.  Gastrointestinal absorption of calcium from milk and calcium salts. , 1987, The New England journal of medicine.

[23]  Theodore L. Brown Chemistry: The Central Science , 1981 .

[24]  R. Heaney Optimal calcium intake. , 1995, JAMA.

[25]  Heinz Valtin,et al.  “ Drink at least eight glasses of water a day . ” Really ? Is there scientific evidence for “ 8 8 ” ? , 2002 .

[26]  Kay Dickersin,et al.  Osteoporosis prevention, diagnosis, and therapy. , 2000, NIH consensus statement.

[27]  B. Nordin Calcium requirement is a sliding scale. , 2000, The American journal of clinical nutrition.

[28]  E. Orwoll,et al.  Alendronate for the treatment of osteoporosis in men. , 2000, The New England journal of medicine.